Review



vector sh exo1  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 88
      Buy from Supplier

    Structured Review

    Santa Cruz Biotechnology vector sh exo1
    Gene expression profile in PLCε-silenced T24 cells and verification of selected DEGs. (A) RNA-seq mRNA expression data from Sanchez-Carbayo bladder dataset was used to compare PLCε expression between in BCa tumors (BCa) and normal bladder tissue (Bladder). (B) KEGG pathway enrichment analysis for the DEGs (> two-fold change and P < 0.05), the vertical axis was the pathway category, and the horizontal axis was the enrichment of pathways. (C) The significant GO category for indicated genes of mismatch repair between Ad-shPLCε and Ad-NC groups, the vertical axis was the GO terms, and the horizontal axis was the enrichment of GO, P value < 0.01 was used as a threshold to select significant GO categories. (D) Hierarchical clustering analysis of DEGs involved in DNA damage repair pathways. High expression levels are shown in green and low levels in red. (E, F) Detection gene levels of 4 selected DEGs by q-PCR in T24 and BIU-87 cells. The q-PCR data were normalized to the expression of β-actin (G) RNA-seq mRNA expression data from the TCGA to compare <t>EXO1</t> expression between in BCa tumors (T) and their non-tumor counterparts (N). *P ≤ 0.05, **P ≤ 0.01, AND ***P < 0.001.
    Vector Sh Exo1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 88/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vector sh exo1/product/Santa Cruz Biotechnology
    Average 88 stars, based on 8 article reviews
    vector sh exo1 - by Bioz Stars, 2026-02
    88/100 stars

    Images

    1) Product Images from "Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1"

    Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

    Journal: American Journal of Cancer Research

    doi:

    Gene expression profile in PLCε-silenced T24 cells and verification of selected DEGs. (A) RNA-seq mRNA expression data from Sanchez-Carbayo bladder dataset was used to compare PLCε expression between in BCa tumors (BCa) and normal bladder tissue (Bladder). (B) KEGG pathway enrichment analysis for the DEGs (> two-fold change and P < 0.05), the vertical axis was the pathway category, and the horizontal axis was the enrichment of pathways. (C) The significant GO category for indicated genes of mismatch repair between Ad-shPLCε and Ad-NC groups, the vertical axis was the GO terms, and the horizontal axis was the enrichment of GO, P value < 0.01 was used as a threshold to select significant GO categories. (D) Hierarchical clustering analysis of DEGs involved in DNA damage repair pathways. High expression levels are shown in green and low levels in red. (E, F) Detection gene levels of 4 selected DEGs by q-PCR in T24 and BIU-87 cells. The q-PCR data were normalized to the expression of β-actin (G) RNA-seq mRNA expression data from the TCGA to compare EXO1 expression between in BCa tumors (T) and their non-tumor counterparts (N). *P ≤ 0.05, **P ≤ 0.01, AND ***P < 0.001.
    Figure Legend Snippet: Gene expression profile in PLCε-silenced T24 cells and verification of selected DEGs. (A) RNA-seq mRNA expression data from Sanchez-Carbayo bladder dataset was used to compare PLCε expression between in BCa tumors (BCa) and normal bladder tissue (Bladder). (B) KEGG pathway enrichment analysis for the DEGs (> two-fold change and P < 0.05), the vertical axis was the pathway category, and the horizontal axis was the enrichment of pathways. (C) The significant GO category for indicated genes of mismatch repair between Ad-shPLCε and Ad-NC groups, the vertical axis was the GO terms, and the horizontal axis was the enrichment of GO, P value < 0.01 was used as a threshold to select significant GO categories. (D) Hierarchical clustering analysis of DEGs involved in DNA damage repair pathways. High expression levels are shown in green and low levels in red. (E, F) Detection gene levels of 4 selected DEGs by q-PCR in T24 and BIU-87 cells. The q-PCR data were normalized to the expression of β-actin (G) RNA-seq mRNA expression data from the TCGA to compare EXO1 expression between in BCa tumors (T) and their non-tumor counterparts (N). *P ≤ 0.05, **P ≤ 0.01, AND ***P < 0.001.

    Techniques Used: Expressing, RNA Sequencing Assay

    High expression levels of PLCε and EXO1 in BCa tissues. (A, B) Disease free survival curves of BCa patients according to EXO1 and ATM mRNA levels in TCGA. (C) Representative haematoxyl in and eosin (H&E) staining and IHC staining in 72 BCa tissue samples and 24 corresponding adjacent non-neoplastic (BN) samples. Magnification × 200. Bars = 150 μm. H&E staining of bladder tissues were showed (a and i). Representative IHC staining of different staining intensities used as criteria in staining scoring: none staining was observed in BN (b-d), positive staining in BCa (j-l). PLCε localized in cytoplasm. EXO1 and ATM protein localized in nucleus. Images in the frame of (a-d and i-l) were enlarged to (e-h and m-p). (D-F) Average staining scores for PLCε, EXO1, and ATM expression in bladder tissues. (G, H) The correlation with PLCε and EXO1 expression and EXO1 and ATM expression in bladder tissues samples was analyzed by Pearson analysis. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.
    Figure Legend Snippet: High expression levels of PLCε and EXO1 in BCa tissues. (A, B) Disease free survival curves of BCa patients according to EXO1 and ATM mRNA levels in TCGA. (C) Representative haematoxyl in and eosin (H&E) staining and IHC staining in 72 BCa tissue samples and 24 corresponding adjacent non-neoplastic (BN) samples. Magnification × 200. Bars = 150 μm. H&E staining of bladder tissues were showed (a and i). Representative IHC staining of different staining intensities used as criteria in staining scoring: none staining was observed in BN (b-d), positive staining in BCa (j-l). PLCε localized in cytoplasm. EXO1 and ATM protein localized in nucleus. Images in the frame of (a-d and i-l) were enlarged to (e-h and m-p). (D-F) Average staining scores for PLCε, EXO1, and ATM expression in bladder tissues. (G, H) The correlation with PLCε and EXO1 expression and EXO1 and ATM expression in bladder tissues samples was analyzed by Pearson analysis. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Techniques Used: Expressing, Staining, Immunohistochemistry

    Correlation between PLCε, EXO1 and ATM expressions and the corresponding clinicopathological parameter in BCa patients
    Figure Legend Snippet: Correlation between PLCε, EXO1 and ATM expressions and the corresponding clinicopathological parameter in BCa patients

    Techniques Used:

    A association between PLCε and EXO1 expression in BCa patients. A. PLCε and EXO1 protein expression in 24 BCa tissue samples (T) and 24 BN samples (N) were assayed by western blotting analysis. B, C. PLCε and EXO1 protein expression in tissues were quantified as mean optical density by Image J software. D, E. PLCε and EXO1 protein expression in tissues were assayed by Statistical analysis. F. Correlation curve of PLCε protein versus corresponding EXO1 by Statistical analysis. G. Western blotting analysis detected the expression of PLCε and EXO1 in two human BCa cell lines and SV-HUC-1 cells. H, I. Detection of PLCε and EXO1 by qPCR. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.
    Figure Legend Snippet: A association between PLCε and EXO1 expression in BCa patients. A. PLCε and EXO1 protein expression in 24 BCa tissue samples (T) and 24 BN samples (N) were assayed by western blotting analysis. B, C. PLCε and EXO1 protein expression in tissues were quantified as mean optical density by Image J software. D, E. PLCε and EXO1 protein expression in tissues were assayed by Statistical analysis. F. Correlation curve of PLCε protein versus corresponding EXO1 by Statistical analysis. G. Western blotting analysis detected the expression of PLCε and EXO1 in two human BCa cell lines and SV-HUC-1 cells. H, I. Detection of PLCε and EXO1 by qPCR. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Techniques Used: Expressing, Western Blot, Software

    PLCε depletion inhibit cell proliferation, induce G1 phase cell cycle arrest, apoptosis and cisplatin sensitivity. A. The T24 and BIU-87 cells were infected with adenovirus sh-PLCε, western blotting were detected the expression of PLCε. B. Western blotting analysis detected the expression of EXO1, cyclinD1, c-Myc, PCNA, BCL2, caspase 3, caspase 9 and BAX. C, D. Representative flow cytometry analysis of cell cycle phase distribution after 48 h of culture, compared to blank group. E-K. The T24 and BIU-87 cells were infected with vector-EXO1 for 72 h. E, F. Representative flow cytometry analysis of cell apoptosis after 72 h of culture in Ad-shPLCε or/and EXO1 groups. G, H. Clone formation analysis was employed to test the cell proliferation in Ad-shPLCε or/and EXO1 groups. I. IC50 values were measured by CCK-8 to compare the susceptibility of the three cell lines to cisplatin. J, K. IC50 values of T24 and BIU were measured by CCK-8 Analysis in Ad-shPLCε or/and EXO1 groups. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.
    Figure Legend Snippet: PLCε depletion inhibit cell proliferation, induce G1 phase cell cycle arrest, apoptosis and cisplatin sensitivity. A. The T24 and BIU-87 cells were infected with adenovirus sh-PLCε, western blotting were detected the expression of PLCε. B. Western blotting analysis detected the expression of EXO1, cyclinD1, c-Myc, PCNA, BCL2, caspase 3, caspase 9 and BAX. C, D. Representative flow cytometry analysis of cell cycle phase distribution after 48 h of culture, compared to blank group. E-K. The T24 and BIU-87 cells were infected with vector-EXO1 for 72 h. E, F. Representative flow cytometry analysis of cell apoptosis after 72 h of culture in Ad-shPLCε or/and EXO1 groups. G, H. Clone formation analysis was employed to test the cell proliferation in Ad-shPLCε or/and EXO1 groups. I. IC50 values were measured by CCK-8 to compare the susceptibility of the three cell lines to cisplatin. J, K. IC50 values of T24 and BIU were measured by CCK-8 Analysis in Ad-shPLCε or/and EXO1 groups. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Techniques Used: Infection, Western Blot, Expressing, Flow Cytometry, Plasmid Preparation, CCK-8 Assay

    PLCε regulates EXO1-mediated cell cycle, proliferation and apoptosis through nuclear translocation of p-ATM. A. The BCa cells were infected with vector-shEXO1, western blotting detected the expression of EXO1. B. Western blotting analysis detected the expression of EXO1, cyclinD1, c-Myc, PCNA, BCL2, caspase 3, caspase 9, and BAX in sh-NC and sh-EXO1 groups. C. The BCa cells were infected with vector-EXO1, western blotting detected the expression of EXO1. D. Western blotting analysis detected the expression of PLCε, EXO1, cyclinD1, c-Myc, PCNA, BCL2, caspase 3, caspase 9 and BAX in sh-EXO1 groups or/and Ad-shPLCε groups. E. Detection of p-ATM expression in nuclear and cytoplasm by western blot. F. Western blotting analysis showing that Ad-shPLCε reduced EXO1 level with 13 nM KU-55933 for 48 h. G. Immunofluorescence staining analysis demonstrating that Ad-shPLCε disrupted p-ATM nuclear translocation stimulated by cisplatin. Magnification: 400×. Bars = 100 μm. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.
    Figure Legend Snippet: PLCε regulates EXO1-mediated cell cycle, proliferation and apoptosis through nuclear translocation of p-ATM. A. The BCa cells were infected with vector-shEXO1, western blotting detected the expression of EXO1. B. Western blotting analysis detected the expression of EXO1, cyclinD1, c-Myc, PCNA, BCL2, caspase 3, caspase 9, and BAX in sh-NC and sh-EXO1 groups. C. The BCa cells were infected with vector-EXO1, western blotting detected the expression of EXO1. D. Western blotting analysis detected the expression of PLCε, EXO1, cyclinD1, c-Myc, PCNA, BCL2, caspase 3, caspase 9 and BAX in sh-EXO1 groups or/and Ad-shPLCε groups. E. Detection of p-ATM expression in nuclear and cytoplasm by western blot. F. Western blotting analysis showing that Ad-shPLCε reduced EXO1 level with 13 nM KU-55933 for 48 h. G. Immunofluorescence staining analysis demonstrating that Ad-shPLCε disrupted p-ATM nuclear translocation stimulated by cisplatin. Magnification: 400×. Bars = 100 μm. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Techniques Used: Translocation Assay, Infection, Plasmid Preparation, Western Blot, Expressing, Immunofluorescence, Staining

    PLCε depletion enhanced the inhibitory effect of cisplatin on the growth of BCa cells. C-I. 8 μg/mL Cisplatin was treated in BCa cells for 48 h. A, B. Western blotting analysis showing the expressions of EXO1 and γ-H2AX stimulated by cisplatin at different concentrations (for 24 h) and different treat times (with 8 μg/mL) in BCa cells. C. Morphological change of bladder cancer cells with cisplatin or (and) Ad-shPLCε treatment. Magnification: 200×. Bars = 100 μm. D, E. Representative flow cytometry analysis of cell cycle phase distribution after 48 h of culture, compared to blank group. F. Western blotting detected the expression of cell cycle and proliferation related proteins. G, H. Clone formation analysis was employed to test the cell proliferation of BCa cell lines after treatment with cisplatin. I. Western blotting detected the expression of cell apoptosis related proteins. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.
    Figure Legend Snippet: PLCε depletion enhanced the inhibitory effect of cisplatin on the growth of BCa cells. C-I. 8 μg/mL Cisplatin was treated in BCa cells for 48 h. A, B. Western blotting analysis showing the expressions of EXO1 and γ-H2AX stimulated by cisplatin at different concentrations (for 24 h) and different treat times (with 8 μg/mL) in BCa cells. C. Morphological change of bladder cancer cells with cisplatin or (and) Ad-shPLCε treatment. Magnification: 200×. Bars = 100 μm. D, E. Representative flow cytometry analysis of cell cycle phase distribution after 48 h of culture, compared to blank group. F. Western blotting detected the expression of cell cycle and proliferation related proteins. G, H. Clone formation analysis was employed to test the cell proliferation of BCa cell lines after treatment with cisplatin. I. Western blotting detected the expression of cell apoptosis related proteins. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Techniques Used: Western Blot, Flow Cytometry, Expressing

    Decreased levels of serum miR-145 in BCa patients and PLCε was a direct target of miR-145 in BCa cells. A. Comparison of miR-145 levels in three cell lines by qPCR. vs SV-HUC-1. B. Expression levels of miR-145 in T24 and BIU cells transfected with miR-145 mimics and NC. C, D. PLCε mRNA and protein expression levels in the BCa cell lines detected by qRT-PCR and western blotting after transfection with miR-145 mimics. E. Schematic representation of the predicted miR-145 binding sites in 3’UTR of PLCε. F. Wild-type or mutant 3’UTR of PLCε gene reporter plasmid was co-transfected with miR-145mimics or NC into T24, followed by luciferase reporter assays. vs miR-NC. G. Changes of PLCε expression analysised by qPCR in BCa cells after treating with cisplatin or (and) miR-145. H, I. 8 μg/mL Cisplatin was treated in BCa cells for 48 h. H. Viability of BCa cells with cisplatin or (and) miR-145 mimics treatment detected by CCK-8. I. Western blotting analysis showing the expression of PLCε, EXO1, and γH2AX after cisplatin or (and) miR-145 mimics treatment for 48 h. J. The serum miR-145 expression in 40 patients with BCa, 19 patients with urinary benign diseases (BBD) and 21 healthy controls (Normal) were obtained by qPCR. Expression levels of miR-145 were normalized to U6. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.
    Figure Legend Snippet: Decreased levels of serum miR-145 in BCa patients and PLCε was a direct target of miR-145 in BCa cells. A. Comparison of miR-145 levels in three cell lines by qPCR. vs SV-HUC-1. B. Expression levels of miR-145 in T24 and BIU cells transfected with miR-145 mimics and NC. C, D. PLCε mRNA and protein expression levels in the BCa cell lines detected by qRT-PCR and western blotting after transfection with miR-145 mimics. E. Schematic representation of the predicted miR-145 binding sites in 3’UTR of PLCε. F. Wild-type or mutant 3’UTR of PLCε gene reporter plasmid was co-transfected with miR-145mimics or NC into T24, followed by luciferase reporter assays. vs miR-NC. G. Changes of PLCε expression analysised by qPCR in BCa cells after treating with cisplatin or (and) miR-145. H, I. 8 μg/mL Cisplatin was treated in BCa cells for 48 h. H. Viability of BCa cells with cisplatin or (and) miR-145 mimics treatment detected by CCK-8. I. Western blotting analysis showing the expression of PLCε, EXO1, and γH2AX after cisplatin or (and) miR-145 mimics treatment for 48 h. J. The serum miR-145 expression in 40 patients with BCa, 19 patients with urinary benign diseases (BBD) and 21 healthy controls (Normal) were obtained by qPCR. Expression levels of miR-145 were normalized to U6. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Techniques Used: Expressing, Transfection, Quantitative RT-PCR, Western Blot, Binding Assay, Mutagenesis, Plasmid Preparation, Luciferase, CCK-8 Assay

    A mechanism for PLCε depletion-mediated cisplatin sensitivity of BCa. Schematic diagram describing the functional significance of PLCε in BCa cells. PLCε regulate EXO1 medicated-cell cycle, proliferation, apoptosis and cisplatin sensitivity through nuclear translocation of p-ATM and can be regulated by miR-145.
    Figure Legend Snippet: A mechanism for PLCε depletion-mediated cisplatin sensitivity of BCa. Schematic diagram describing the functional significance of PLCε in BCa cells. PLCε regulate EXO1 medicated-cell cycle, proliferation, apoptosis and cisplatin sensitivity through nuclear translocation of p-ATM and can be regulated by miR-145.

    Techniques Used: Functional Assay, Translocation Assay



    Similar Products

    vector sh exo1  (OriGene)
    90
    OriGene vector sh exo1
    Gene expression profile in PLCε-silenced T24 cells and verification of selected DEGs. (A) RNA-seq mRNA expression data from Sanchez-Carbayo bladder dataset was used to compare PLCε expression between in BCa tumors (BCa) and normal bladder tissue (Bladder). (B) KEGG pathway enrichment analysis for the DEGs (> two-fold change and P < 0.05), the vertical axis was the pathway category, and the horizontal axis was the enrichment of pathways. (C) The significant GO category for indicated genes of mismatch repair between Ad-shPLCε and Ad-NC groups, the vertical axis was the GO terms, and the horizontal axis was the enrichment of GO, P value < 0.01 was used as a threshold to select significant GO categories. (D) Hierarchical clustering analysis of DEGs involved in DNA damage repair pathways. High expression levels are shown in green and low levels in red. (E, F) Detection gene levels of 4 selected DEGs by q-PCR in T24 and BIU-87 cells. The q-PCR data were normalized to the expression of β-actin (G) RNA-seq mRNA expression data from the TCGA to compare <t>EXO1</t> expression between in BCa tumors (T) and their non-tumor counterparts (N). *P ≤ 0.05, **P ≤ 0.01, AND ***P < 0.001.
    Vector Sh Exo1, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vector sh exo1/product/OriGene
    Average 90 stars, based on 1 article reviews
    vector sh exo1 - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    vector sh exo1  (Santa Cruz Biotechnology)
    88
    Santa Cruz Biotechnology vector sh exo1
    Gene expression profile in PLCε-silenced T24 cells and verification of selected DEGs. (A) RNA-seq mRNA expression data from Sanchez-Carbayo bladder dataset was used to compare PLCε expression between in BCa tumors (BCa) and normal bladder tissue (Bladder). (B) KEGG pathway enrichment analysis for the DEGs (> two-fold change and P < 0.05), the vertical axis was the pathway category, and the horizontal axis was the enrichment of pathways. (C) The significant GO category for indicated genes of mismatch repair between Ad-shPLCε and Ad-NC groups, the vertical axis was the GO terms, and the horizontal axis was the enrichment of GO, P value < 0.01 was used as a threshold to select significant GO categories. (D) Hierarchical clustering analysis of DEGs involved in DNA damage repair pathways. High expression levels are shown in green and low levels in red. (E, F) Detection gene levels of 4 selected DEGs by q-PCR in T24 and BIU-87 cells. The q-PCR data were normalized to the expression of β-actin (G) RNA-seq mRNA expression data from the TCGA to compare <t>EXO1</t> expression between in BCa tumors (T) and their non-tumor counterparts (N). *P ≤ 0.05, **P ≤ 0.01, AND ***P < 0.001.
    Vector Sh Exo1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vector sh exo1/product/Santa Cruz Biotechnology
    Average 88 stars, based on 1 article reviews
    vector sh exo1 - by Bioz Stars, 2026-02
    88/100 stars
    		  Buy from Supplier
    scrambled shrna vectors  (Santa Cruz Biotechnology)
    88
    Santa Cruz Biotechnology scrambled shrna vectors
    Gene expression profile in PLCε-silenced T24 cells and verification of selected DEGs. (A) RNA-seq mRNA expression data from Sanchez-Carbayo bladder dataset was used to compare PLCε expression between in BCa tumors (BCa) and normal bladder tissue (Bladder). (B) KEGG pathway enrichment analysis for the DEGs (> two-fold change and P < 0.05), the vertical axis was the pathway category, and the horizontal axis was the enrichment of pathways. (C) The significant GO category for indicated genes of mismatch repair between Ad-shPLCε and Ad-NC groups, the vertical axis was the GO terms, and the horizontal axis was the enrichment of GO, P value < 0.01 was used as a threshold to select significant GO categories. (D) Hierarchical clustering analysis of DEGs involved in DNA damage repair pathways. High expression levels are shown in green and low levels in red. (E, F) Detection gene levels of 4 selected DEGs by q-PCR in T24 and BIU-87 cells. The q-PCR data were normalized to the expression of β-actin (G) RNA-seq mRNA expression data from the TCGA to compare <t>EXO1</t> expression between in BCa tumors (T) and their non-tumor counterparts (N). *P ≤ 0.05, **P ≤ 0.01, AND ***P < 0.001.
    Scrambled Shrna Vectors, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/scrambled shrna vectors/product/Santa Cruz Biotechnology
    Average 88 stars, based on 1 article reviews
    scrambled shrna vectors - by Bioz Stars, 2026-02
    88/100 stars
    		  Buy from Supplier

    Image Search Results


    Gene expression profile in PLCε-silenced T24 cells and verification of selected DEGs. (A) RNA-seq mRNA expression data from Sanchez-Carbayo bladder dataset was used to compare PLCε expression between in BCa tumors (BCa) and normal bladder tissue (Bladder). (B) KEGG pathway enrichment analysis for the DEGs (> two-fold change and P < 0.05), the vertical axis was the pathway category, and the horizontal axis was the enrichment of pathways. (C) The significant GO category for indicated genes of mismatch repair between Ad-shPLCε and Ad-NC groups, the vertical axis was the GO terms, and the horizontal axis was the enrichment of GO, P value < 0.01 was used as a threshold to select significant GO categories. (D) Hierarchical clustering analysis of DEGs involved in DNA damage repair pathways. High expression levels are shown in green and low levels in red. (E, F) Detection gene levels of 4 selected DEGs by q-PCR in T24 and BIU-87 cells. The q-PCR data were normalized to the expression of β-actin (G) RNA-seq mRNA expression data from the TCGA to compare EXO1 expression between in BCa tumors (T) and their non-tumor counterparts (N). *P ≤ 0.05, **P ≤ 0.01, AND ***P < 0.001.

    Journal: American Journal of Cancer Research

    Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

    doi:

    Figure Lengend Snippet: Gene expression profile in PLCε-silenced T24 cells and verification of selected DEGs. (A) RNA-seq mRNA expression data from Sanchez-Carbayo bladder dataset was used to compare PLCε expression between in BCa tumors (BCa) and normal bladder tissue (Bladder). (B) KEGG pathway enrichment analysis for the DEGs (> two-fold change and P < 0.05), the vertical axis was the pathway category, and the horizontal axis was the enrichment of pathways. (C) The significant GO category for indicated genes of mismatch repair between Ad-shPLCε and Ad-NC groups, the vertical axis was the GO terms, and the horizontal axis was the enrichment of GO, P value < 0.01 was used as a threshold to select significant GO categories. (D) Hierarchical clustering analysis of DEGs involved in DNA damage repair pathways. High expression levels are shown in green and low levels in red. (E, F) Detection gene levels of 4 selected DEGs by q-PCR in T24 and BIU-87 cells. The q-PCR data were normalized to the expression of β-actin (G) RNA-seq mRNA expression data from the TCGA to compare EXO1 expression between in BCa tumors (T) and their non-tumor counterparts (N). *P ≤ 0.05, **P ≤ 0.01, AND ***P < 0.001.

    Article Snippet: EXO1 human tagged ORF clone vector (RC200547), pCMV6-Entry vevtor (PS10001), vector-sh-EXO1#1 (TR304725) and vector-sh-NC (TR20003) were purchased from OriGene Technologies.

    Techniques: Expressing, RNA Sequencing Assay

    High expression levels of PLCε and EXO1 in BCa tissues. (A, B) Disease free survival curves of BCa patients according to EXO1 and ATM mRNA levels in TCGA. (C) Representative haematoxyl in and eosin (H&E) staining and IHC staining in 72 BCa tissue samples and 24 corresponding adjacent non-neoplastic (BN) samples. Magnification × 200. Bars = 150 μm. H&E staining of bladder tissues were showed (a and i). Representative IHC staining of different staining intensities used as criteria in staining scoring: none staining was observed in BN (b-d), positive staining in BCa (j-l). PLCε localized in cytoplasm. EXO1 and ATM protein localized in nucleus. Images in the frame of (a-d and i-l) were enlarged to (e-h and m-p). (D-F) Average staining scores for PLCε, EXO1, and ATM expression in bladder tissues. (G, H) The correlation with PLCε and EXO1 expression and EXO1 and ATM expression in bladder tissues samples was analyzed by Pearson analysis. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Journal: American Journal of Cancer Research

    Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

    doi:

    Figure Lengend Snippet: High expression levels of PLCε and EXO1 in BCa tissues. (A, B) Disease free survival curves of BCa patients according to EXO1 and ATM mRNA levels in TCGA. (C) Representative haematoxyl in and eosin (H&E) staining and IHC staining in 72 BCa tissue samples and 24 corresponding adjacent non-neoplastic (BN) samples. Magnification × 200. Bars = 150 μm. H&E staining of bladder tissues were showed (a and i). Representative IHC staining of different staining intensities used as criteria in staining scoring: none staining was observed in BN (b-d), positive staining in BCa (j-l). PLCε localized in cytoplasm. EXO1 and ATM protein localized in nucleus. Images in the frame of (a-d and i-l) were enlarged to (e-h and m-p). (D-F) Average staining scores for PLCε, EXO1, and ATM expression in bladder tissues. (G, H) The correlation with PLCε and EXO1 expression and EXO1 and ATM expression in bladder tissues samples was analyzed by Pearson analysis. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Article Snippet: EXO1 human tagged ORF clone vector (RC200547), pCMV6-Entry vevtor (PS10001), vector-sh-EXO1#1 (TR304725) and vector-sh-NC (TR20003) were purchased from OriGene Technologies.

    Techniques: Expressing, Staining, Immunohistochemistry

    Correlation between PLCε, EXO1 and ATM expressions and the corresponding clinicopathological parameter in BCa patients

    Journal: American Journal of Cancer Research

    Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

    doi:

    Figure Lengend Snippet: Correlation between PLCε, EXO1 and ATM expressions and the corresponding clinicopathological parameter in BCa patients

    Article Snippet: EXO1 human tagged ORF clone vector (RC200547), pCMV6-Entry vevtor (PS10001), vector-sh-EXO1#1 (TR304725) and vector-sh-NC (TR20003) were purchased from OriGene Technologies.

    Techniques:

    A association between PLCε and EXO1 expression in BCa patients. A. PLCε and EXO1 protein expression in 24 BCa tissue samples (T) and 24 BN samples (N) were assayed by western blotting analysis. B, C. PLCε and EXO1 protein expression in tissues were quantified as mean optical density by Image J software. D, E. PLCε and EXO1 protein expression in tissues were assayed by Statistical analysis. F. Correlation curve of PLCε protein versus corresponding EXO1 by Statistical analysis. G. Western blotting analysis detected the expression of PLCε and EXO1 in two human BCa cell lines and SV-HUC-1 cells. H, I. Detection of PLCε and EXO1 by qPCR. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Journal: American Journal of Cancer Research

    Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

    doi:

    Figure Lengend Snippet: A association between PLCε and EXO1 expression in BCa patients. A. PLCε and EXO1 protein expression in 24 BCa tissue samples (T) and 24 BN samples (N) were assayed by western blotting analysis. B, C. PLCε and EXO1 protein expression in tissues were quantified as mean optical density by Image J software. D, E. PLCε and EXO1 protein expression in tissues were assayed by Statistical analysis. F. Correlation curve of PLCε protein versus corresponding EXO1 by Statistical analysis. G. Western blotting analysis detected the expression of PLCε and EXO1 in two human BCa cell lines and SV-HUC-1 cells. H, I. Detection of PLCε and EXO1 by qPCR. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Article Snippet: EXO1 human tagged ORF clone vector (RC200547), pCMV6-Entry vevtor (PS10001), vector-sh-EXO1#1 (TR304725) and vector-sh-NC (TR20003) were purchased from OriGene Technologies.

    Techniques: Expressing, Western Blot, Software

    PLCε depletion inhibit cell proliferation, induce G1 phase cell cycle arrest, apoptosis and cisplatin sensitivity. A. The T24 and BIU-87 cells were infected with adenovirus sh-PLCε, western blotting were detected the expression of PLCε. B. Western blotting analysis detected the expression of EXO1, cyclinD1, c-Myc, PCNA, BCL2, caspase 3, caspase 9 and BAX. C, D. Representative flow cytometry analysis of cell cycle phase distribution after 48 h of culture, compared to blank group. E-K. The T24 and BIU-87 cells were infected with vector-EXO1 for 72 h. E, F. Representative flow cytometry analysis of cell apoptosis after 72 h of culture in Ad-shPLCε or/and EXO1 groups. G, H. Clone formation analysis was employed to test the cell proliferation in Ad-shPLCε or/and EXO1 groups. I. IC50 values were measured by CCK-8 to compare the susceptibility of the three cell lines to cisplatin. J, K. IC50 values of T24 and BIU were measured by CCK-8 Analysis in Ad-shPLCε or/and EXO1 groups. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Journal: American Journal of Cancer Research

    Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

    doi:

    Figure Lengend Snippet: PLCε depletion inhibit cell proliferation, induce G1 phase cell cycle arrest, apoptosis and cisplatin sensitivity. A. The T24 and BIU-87 cells were infected with adenovirus sh-PLCε, western blotting were detected the expression of PLCε. B. Western blotting analysis detected the expression of EXO1, cyclinD1, c-Myc, PCNA, BCL2, caspase 3, caspase 9 and BAX. C, D. Representative flow cytometry analysis of cell cycle phase distribution after 48 h of culture, compared to blank group. E-K. The T24 and BIU-87 cells were infected with vector-EXO1 for 72 h. E, F. Representative flow cytometry analysis of cell apoptosis after 72 h of culture in Ad-shPLCε or/and EXO1 groups. G, H. Clone formation analysis was employed to test the cell proliferation in Ad-shPLCε or/and EXO1 groups. I. IC50 values were measured by CCK-8 to compare the susceptibility of the three cell lines to cisplatin. J, K. IC50 values of T24 and BIU were measured by CCK-8 Analysis in Ad-shPLCε or/and EXO1 groups. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Article Snippet: EXO1 human tagged ORF clone vector (RC200547), pCMV6-Entry vevtor (PS10001), vector-sh-EXO1#1 (TR304725) and vector-sh-NC (TR20003) were purchased from OriGene Technologies.

    Techniques: Infection, Western Blot, Expressing, Flow Cytometry, Plasmid Preparation, CCK-8 Assay

    PLCε regulates EXO1-mediated cell cycle, proliferation and apoptosis through nuclear translocation of p-ATM. A. The BCa cells were infected with vector-shEXO1, western blotting detected the expression of EXO1. B. Western blotting analysis detected the expression of EXO1, cyclinD1, c-Myc, PCNA, BCL2, caspase 3, caspase 9, and BAX in sh-NC and sh-EXO1 groups. C. The BCa cells were infected with vector-EXO1, western blotting detected the expression of EXO1. D. Western blotting analysis detected the expression of PLCε, EXO1, cyclinD1, c-Myc, PCNA, BCL2, caspase 3, caspase 9 and BAX in sh-EXO1 groups or/and Ad-shPLCε groups. E. Detection of p-ATM expression in nuclear and cytoplasm by western blot. F. Western blotting analysis showing that Ad-shPLCε reduced EXO1 level with 13 nM KU-55933 for 48 h. G. Immunofluorescence staining analysis demonstrating that Ad-shPLCε disrupted p-ATM nuclear translocation stimulated by cisplatin. Magnification: 400×. Bars = 100 μm. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Journal: American Journal of Cancer Research

    Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

    doi:

    Figure Lengend Snippet: PLCε regulates EXO1-mediated cell cycle, proliferation and apoptosis through nuclear translocation of p-ATM. A. The BCa cells were infected with vector-shEXO1, western blotting detected the expression of EXO1. B. Western blotting analysis detected the expression of EXO1, cyclinD1, c-Myc, PCNA, BCL2, caspase 3, caspase 9, and BAX in sh-NC and sh-EXO1 groups. C. The BCa cells were infected with vector-EXO1, western blotting detected the expression of EXO1. D. Western blotting analysis detected the expression of PLCε, EXO1, cyclinD1, c-Myc, PCNA, BCL2, caspase 3, caspase 9 and BAX in sh-EXO1 groups or/and Ad-shPLCε groups. E. Detection of p-ATM expression in nuclear and cytoplasm by western blot. F. Western blotting analysis showing that Ad-shPLCε reduced EXO1 level with 13 nM KU-55933 for 48 h. G. Immunofluorescence staining analysis demonstrating that Ad-shPLCε disrupted p-ATM nuclear translocation stimulated by cisplatin. Magnification: 400×. Bars = 100 μm. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Article Snippet: EXO1 human tagged ORF clone vector (RC200547), pCMV6-Entry vevtor (PS10001), vector-sh-EXO1#1 (TR304725) and vector-sh-NC (TR20003) were purchased from OriGene Technologies.

    Techniques: Translocation Assay, Infection, Plasmid Preparation, Western Blot, Expressing, Immunofluorescence, Staining

    PLCε depletion enhanced the inhibitory effect of cisplatin on the growth of BCa cells. C-I. 8 μg/mL Cisplatin was treated in BCa cells for 48 h. A, B. Western blotting analysis showing the expressions of EXO1 and γ-H2AX stimulated by cisplatin at different concentrations (for 24 h) and different treat times (with 8 μg/mL) in BCa cells. C. Morphological change of bladder cancer cells with cisplatin or (and) Ad-shPLCε treatment. Magnification: 200×. Bars = 100 μm. D, E. Representative flow cytometry analysis of cell cycle phase distribution after 48 h of culture, compared to blank group. F. Western blotting detected the expression of cell cycle and proliferation related proteins. G, H. Clone formation analysis was employed to test the cell proliferation of BCa cell lines after treatment with cisplatin. I. Western blotting detected the expression of cell apoptosis related proteins. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Journal: American Journal of Cancer Research

    Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

    doi:

    Figure Lengend Snippet: PLCε depletion enhanced the inhibitory effect of cisplatin on the growth of BCa cells. C-I. 8 μg/mL Cisplatin was treated in BCa cells for 48 h. A, B. Western blotting analysis showing the expressions of EXO1 and γ-H2AX stimulated by cisplatin at different concentrations (for 24 h) and different treat times (with 8 μg/mL) in BCa cells. C. Morphological change of bladder cancer cells with cisplatin or (and) Ad-shPLCε treatment. Magnification: 200×. Bars = 100 μm. D, E. Representative flow cytometry analysis of cell cycle phase distribution after 48 h of culture, compared to blank group. F. Western blotting detected the expression of cell cycle and proliferation related proteins. G, H. Clone formation analysis was employed to test the cell proliferation of BCa cell lines after treatment with cisplatin. I. Western blotting detected the expression of cell apoptosis related proteins. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Article Snippet: EXO1 human tagged ORF clone vector (RC200547), pCMV6-Entry vevtor (PS10001), vector-sh-EXO1#1 (TR304725) and vector-sh-NC (TR20003) were purchased from OriGene Technologies.

    Techniques: Western Blot, Flow Cytometry, Expressing

    Decreased levels of serum miR-145 in BCa patients and PLCε was a direct target of miR-145 in BCa cells. A. Comparison of miR-145 levels in three cell lines by qPCR. vs SV-HUC-1. B. Expression levels of miR-145 in T24 and BIU cells transfected with miR-145 mimics and NC. C, D. PLCε mRNA and protein expression levels in the BCa cell lines detected by qRT-PCR and western blotting after transfection with miR-145 mimics. E. Schematic representation of the predicted miR-145 binding sites in 3’UTR of PLCε. F. Wild-type or mutant 3’UTR of PLCε gene reporter plasmid was co-transfected with miR-145mimics or NC into T24, followed by luciferase reporter assays. vs miR-NC. G. Changes of PLCε expression analysised by qPCR in BCa cells after treating with cisplatin or (and) miR-145. H, I. 8 μg/mL Cisplatin was treated in BCa cells for 48 h. H. Viability of BCa cells with cisplatin or (and) miR-145 mimics treatment detected by CCK-8. I. Western blotting analysis showing the expression of PLCε, EXO1, and γH2AX after cisplatin or (and) miR-145 mimics treatment for 48 h. J. The serum miR-145 expression in 40 patients with BCa, 19 patients with urinary benign diseases (BBD) and 21 healthy controls (Normal) were obtained by qPCR. Expression levels of miR-145 were normalized to U6. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Journal: American Journal of Cancer Research

    Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

    doi:

    Figure Lengend Snippet: Decreased levels of serum miR-145 in BCa patients and PLCε was a direct target of miR-145 in BCa cells. A. Comparison of miR-145 levels in three cell lines by qPCR. vs SV-HUC-1. B. Expression levels of miR-145 in T24 and BIU cells transfected with miR-145 mimics and NC. C, D. PLCε mRNA and protein expression levels in the BCa cell lines detected by qRT-PCR and western blotting after transfection with miR-145 mimics. E. Schematic representation of the predicted miR-145 binding sites in 3’UTR of PLCε. F. Wild-type or mutant 3’UTR of PLCε gene reporter plasmid was co-transfected with miR-145mimics or NC into T24, followed by luciferase reporter assays. vs miR-NC. G. Changes of PLCε expression analysised by qPCR in BCa cells after treating with cisplatin or (and) miR-145. H, I. 8 μg/mL Cisplatin was treated in BCa cells for 48 h. H. Viability of BCa cells with cisplatin or (and) miR-145 mimics treatment detected by CCK-8. I. Western blotting analysis showing the expression of PLCε, EXO1, and γH2AX after cisplatin or (and) miR-145 mimics treatment for 48 h. J. The serum miR-145 expression in 40 patients with BCa, 19 patients with urinary benign diseases (BBD) and 21 healthy controls (Normal) were obtained by qPCR. Expression levels of miR-145 were normalized to U6. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Article Snippet: EXO1 human tagged ORF clone vector (RC200547), pCMV6-Entry vevtor (PS10001), vector-sh-EXO1#1 (TR304725) and vector-sh-NC (TR20003) were purchased from OriGene Technologies.

    Techniques: Expressing, Transfection, Quantitative RT-PCR, Western Blot, Binding Assay, Mutagenesis, Plasmid Preparation, Luciferase, CCK-8 Assay

    A mechanism for PLCε depletion-mediated cisplatin sensitivity of BCa. Schematic diagram describing the functional significance of PLCε in BCa cells. PLCε regulate EXO1 medicated-cell cycle, proliferation, apoptosis and cisplatin sensitivity through nuclear translocation of p-ATM and can be regulated by miR-145.

    Journal: American Journal of Cancer Research

    Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

    doi:

    Figure Lengend Snippet: A mechanism for PLCε depletion-mediated cisplatin sensitivity of BCa. Schematic diagram describing the functional significance of PLCε in BCa cells. PLCε regulate EXO1 medicated-cell cycle, proliferation, apoptosis and cisplatin sensitivity through nuclear translocation of p-ATM and can be regulated by miR-145.

    Article Snippet: EXO1 human tagged ORF clone vector (RC200547), pCMV6-Entry vevtor (PS10001), vector-sh-EXO1#1 (TR304725) and vector-sh-NC (TR20003) were purchased from OriGene Technologies.

    Techniques: Functional Assay, Translocation Assay

    Gene expression profile in PLCε-silenced T24 cells and verification of selected DEGs. (A) RNA-seq mRNA expression data from Sanchez-Carbayo bladder dataset was used to compare PLCε expression between in BCa tumors (BCa) and normal bladder tissue (Bladder). (B) KEGG pathway enrichment analysis for the DEGs (> two-fold change and P < 0.05), the vertical axis was the pathway category, and the horizontal axis was the enrichment of pathways. (C) The significant GO category for indicated genes of mismatch repair between Ad-shPLCε and Ad-NC groups, the vertical axis was the GO terms, and the horizontal axis was the enrichment of GO, P value < 0.01 was used as a threshold to select significant GO categories. (D) Hierarchical clustering analysis of DEGs involved in DNA damage repair pathways. High expression levels are shown in green and low levels in red. (E, F) Detection gene levels of 4 selected DEGs by q-PCR in T24 and BIU-87 cells. The q-PCR data were normalized to the expression of β-actin (G) RNA-seq mRNA expression data from the TCGA to compare EXO1 expression between in BCa tumors (T) and their non-tumor counterparts (N). *P ≤ 0.05, **P ≤ 0.01, AND ***P < 0.001.

    Journal: American Journal of Cancer Research

    Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

    doi:

    Figure Lengend Snippet: Gene expression profile in PLCε-silenced T24 cells and verification of selected DEGs. (A) RNA-seq mRNA expression data from Sanchez-Carbayo bladder dataset was used to compare PLCε expression between in BCa tumors (BCa) and normal bladder tissue (Bladder). (B) KEGG pathway enrichment analysis for the DEGs (> two-fold change and P < 0.05), the vertical axis was the pathway category, and the horizontal axis was the enrichment of pathways. (C) The significant GO category for indicated genes of mismatch repair between Ad-shPLCε and Ad-NC groups, the vertical axis was the GO terms, and the horizontal axis was the enrichment of GO, P value < 0.01 was used as a threshold to select significant GO categories. (D) Hierarchical clustering analysis of DEGs involved in DNA damage repair pathways. High expression levels are shown in green and low levels in red. (E, F) Detection gene levels of 4 selected DEGs by q-PCR in T24 and BIU-87 cells. The q-PCR data were normalized to the expression of β-actin (G) RNA-seq mRNA expression data from the TCGA to compare EXO1 expression between in BCa tumors (T) and their non-tumor counterparts (N). *P ≤ 0.05, **P ≤ 0.01, AND ***P < 0.001.

    Article Snippet: Vector-sh-EXO1#2 (sc-44880-SH) was purchased from Santa Cruz Biotechnology.

    Techniques: Expressing, RNA Sequencing Assay

    High expression levels of PLCε and EXO1 in BCa tissues. (A, B) Disease free survival curves of BCa patients according to EXO1 and ATM mRNA levels in TCGA. (C) Representative haematoxyl in and eosin (H&E) staining and IHC staining in 72 BCa tissue samples and 24 corresponding adjacent non-neoplastic (BN) samples. Magnification × 200. Bars = 150 μm. H&E staining of bladder tissues were showed (a and i). Representative IHC staining of different staining intensities used as criteria in staining scoring: none staining was observed in BN (b-d), positive staining in BCa (j-l). PLCε localized in cytoplasm. EXO1 and ATM protein localized in nucleus. Images in the frame of (a-d and i-l) were enlarged to (e-h and m-p). (D-F) Average staining scores for PLCε, EXO1, and ATM expression in bladder tissues. (G, H) The correlation with PLCε and EXO1 expression and EXO1 and ATM expression in bladder tissues samples was analyzed by Pearson analysis. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Journal: American Journal of Cancer Research

    Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

    doi:

    Figure Lengend Snippet: High expression levels of PLCε and EXO1 in BCa tissues. (A, B) Disease free survival curves of BCa patients according to EXO1 and ATM mRNA levels in TCGA. (C) Representative haematoxyl in and eosin (H&E) staining and IHC staining in 72 BCa tissue samples and 24 corresponding adjacent non-neoplastic (BN) samples. Magnification × 200. Bars = 150 μm. H&E staining of bladder tissues were showed (a and i). Representative IHC staining of different staining intensities used as criteria in staining scoring: none staining was observed in BN (b-d), positive staining in BCa (j-l). PLCε localized in cytoplasm. EXO1 and ATM protein localized in nucleus. Images in the frame of (a-d and i-l) were enlarged to (e-h and m-p). (D-F) Average staining scores for PLCε, EXO1, and ATM expression in bladder tissues. (G, H) The correlation with PLCε and EXO1 expression and EXO1 and ATM expression in bladder tissues samples was analyzed by Pearson analysis. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Article Snippet: Vector-sh-EXO1#2 (sc-44880-SH) was purchased from Santa Cruz Biotechnology.

    Techniques: Expressing, Staining, Immunohistochemistry

    Correlation between PLCε, EXO1 and ATM expressions and the corresponding clinicopathological parameter in BCa patients

    Journal: American Journal of Cancer Research

    Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

    doi:

    Figure Lengend Snippet: Correlation between PLCε, EXO1 and ATM expressions and the corresponding clinicopathological parameter in BCa patients

    Article Snippet: Vector-sh-EXO1#2 (sc-44880-SH) was purchased from Santa Cruz Biotechnology.

    Techniques:

    A association between PLCε and EXO1 expression in BCa patients. A. PLCε and EXO1 protein expression in 24 BCa tissue samples (T) and 24 BN samples (N) were assayed by western blotting analysis. B, C. PLCε and EXO1 protein expression in tissues were quantified as mean optical density by Image J software. D, E. PLCε and EXO1 protein expression in tissues were assayed by Statistical analysis. F. Correlation curve of PLCε protein versus corresponding EXO1 by Statistical analysis. G. Western blotting analysis detected the expression of PLCε and EXO1 in two human BCa cell lines and SV-HUC-1 cells. H, I. Detection of PLCε and EXO1 by qPCR. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Journal: American Journal of Cancer Research

    Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

    doi:

    Figure Lengend Snippet: A association between PLCε and EXO1 expression in BCa patients. A. PLCε and EXO1 protein expression in 24 BCa tissue samples (T) and 24 BN samples (N) were assayed by western blotting analysis. B, C. PLCε and EXO1 protein expression in tissues were quantified as mean optical density by Image J software. D, E. PLCε and EXO1 protein expression in tissues were assayed by Statistical analysis. F. Correlation curve of PLCε protein versus corresponding EXO1 by Statistical analysis. G. Western blotting analysis detected the expression of PLCε and EXO1 in two human BCa cell lines and SV-HUC-1 cells. H, I. Detection of PLCε and EXO1 by qPCR. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Article Snippet: Vector-sh-EXO1#2 (sc-44880-SH) was purchased from Santa Cruz Biotechnology.

    Techniques: Expressing, Western Blot, Software

    PLCε depletion inhibit cell proliferation, induce G1 phase cell cycle arrest, apoptosis and cisplatin sensitivity. A. The T24 and BIU-87 cells were infected with adenovirus sh-PLCε, western blotting were detected the expression of PLCε. B. Western blotting analysis detected the expression of EXO1, cyclinD1, c-Myc, PCNA, BCL2, caspase 3, caspase 9 and BAX. C, D. Representative flow cytometry analysis of cell cycle phase distribution after 48 h of culture, compared to blank group. E-K. The T24 and BIU-87 cells were infected with vector-EXO1 for 72 h. E, F. Representative flow cytometry analysis of cell apoptosis after 72 h of culture in Ad-shPLCε or/and EXO1 groups. G, H. Clone formation analysis was employed to test the cell proliferation in Ad-shPLCε or/and EXO1 groups. I. IC50 values were measured by CCK-8 to compare the susceptibility of the three cell lines to cisplatin. J, K. IC50 values of T24 and BIU were measured by CCK-8 Analysis in Ad-shPLCε or/and EXO1 groups. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Journal: American Journal of Cancer Research

    Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

    doi:

    Figure Lengend Snippet: PLCε depletion inhibit cell proliferation, induce G1 phase cell cycle arrest, apoptosis and cisplatin sensitivity. A. The T24 and BIU-87 cells were infected with adenovirus sh-PLCε, western blotting were detected the expression of PLCε. B. Western blotting analysis detected the expression of EXO1, cyclinD1, c-Myc, PCNA, BCL2, caspase 3, caspase 9 and BAX. C, D. Representative flow cytometry analysis of cell cycle phase distribution after 48 h of culture, compared to blank group. E-K. The T24 and BIU-87 cells were infected with vector-EXO1 for 72 h. E, F. Representative flow cytometry analysis of cell apoptosis after 72 h of culture in Ad-shPLCε or/and EXO1 groups. G, H. Clone formation analysis was employed to test the cell proliferation in Ad-shPLCε or/and EXO1 groups. I. IC50 values were measured by CCK-8 to compare the susceptibility of the three cell lines to cisplatin. J, K. IC50 values of T24 and BIU were measured by CCK-8 Analysis in Ad-shPLCε or/and EXO1 groups. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Article Snippet: Vector-sh-EXO1#2 (sc-44880-SH) was purchased from Santa Cruz Biotechnology.

    Techniques: Infection, Western Blot, Expressing, Flow Cytometry, Plasmid Preparation, CCK-8 Assay

    PLCε regulates EXO1-mediated cell cycle, proliferation and apoptosis through nuclear translocation of p-ATM. A. The BCa cells were infected with vector-shEXO1, western blotting detected the expression of EXO1. B. Western blotting analysis detected the expression of EXO1, cyclinD1, c-Myc, PCNA, BCL2, caspase 3, caspase 9, and BAX in sh-NC and sh-EXO1 groups. C. The BCa cells were infected with vector-EXO1, western blotting detected the expression of EXO1. D. Western blotting analysis detected the expression of PLCε, EXO1, cyclinD1, c-Myc, PCNA, BCL2, caspase 3, caspase 9 and BAX in sh-EXO1 groups or/and Ad-shPLCε groups. E. Detection of p-ATM expression in nuclear and cytoplasm by western blot. F. Western blotting analysis showing that Ad-shPLCε reduced EXO1 level with 13 nM KU-55933 for 48 h. G. Immunofluorescence staining analysis demonstrating that Ad-shPLCε disrupted p-ATM nuclear translocation stimulated by cisplatin. Magnification: 400×. Bars = 100 μm. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Journal: American Journal of Cancer Research

    Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

    doi:

    Figure Lengend Snippet: PLCε regulates EXO1-mediated cell cycle, proliferation and apoptosis through nuclear translocation of p-ATM. A. The BCa cells were infected with vector-shEXO1, western blotting detected the expression of EXO1. B. Western blotting analysis detected the expression of EXO1, cyclinD1, c-Myc, PCNA, BCL2, caspase 3, caspase 9, and BAX in sh-NC and sh-EXO1 groups. C. The BCa cells were infected with vector-EXO1, western blotting detected the expression of EXO1. D. Western blotting analysis detected the expression of PLCε, EXO1, cyclinD1, c-Myc, PCNA, BCL2, caspase 3, caspase 9 and BAX in sh-EXO1 groups or/and Ad-shPLCε groups. E. Detection of p-ATM expression in nuclear and cytoplasm by western blot. F. Western blotting analysis showing that Ad-shPLCε reduced EXO1 level with 13 nM KU-55933 for 48 h. G. Immunofluorescence staining analysis demonstrating that Ad-shPLCε disrupted p-ATM nuclear translocation stimulated by cisplatin. Magnification: 400×. Bars = 100 μm. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Article Snippet: Vector-sh-EXO1#2 (sc-44880-SH) was purchased from Santa Cruz Biotechnology.

    Techniques: Translocation Assay, Infection, Plasmid Preparation, Western Blot, Expressing, Immunofluorescence, Staining

    PLCε depletion enhanced the inhibitory effect of cisplatin on the growth of BCa cells. C-I. 8 μg/mL Cisplatin was treated in BCa cells for 48 h. A, B. Western blotting analysis showing the expressions of EXO1 and γ-H2AX stimulated by cisplatin at different concentrations (for 24 h) and different treat times (with 8 μg/mL) in BCa cells. C. Morphological change of bladder cancer cells with cisplatin or (and) Ad-shPLCε treatment. Magnification: 200×. Bars = 100 μm. D, E. Representative flow cytometry analysis of cell cycle phase distribution after 48 h of culture, compared to blank group. F. Western blotting detected the expression of cell cycle and proliferation related proteins. G, H. Clone formation analysis was employed to test the cell proliferation of BCa cell lines after treatment with cisplatin. I. Western blotting detected the expression of cell apoptosis related proteins. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Journal: American Journal of Cancer Research

    Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

    doi:

    Figure Lengend Snippet: PLCε depletion enhanced the inhibitory effect of cisplatin on the growth of BCa cells. C-I. 8 μg/mL Cisplatin was treated in BCa cells for 48 h. A, B. Western blotting analysis showing the expressions of EXO1 and γ-H2AX stimulated by cisplatin at different concentrations (for 24 h) and different treat times (with 8 μg/mL) in BCa cells. C. Morphological change of bladder cancer cells with cisplatin or (and) Ad-shPLCε treatment. Magnification: 200×. Bars = 100 μm. D, E. Representative flow cytometry analysis of cell cycle phase distribution after 48 h of culture, compared to blank group. F. Western blotting detected the expression of cell cycle and proliferation related proteins. G, H. Clone formation analysis was employed to test the cell proliferation of BCa cell lines after treatment with cisplatin. I. Western blotting detected the expression of cell apoptosis related proteins. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Article Snippet: Vector-sh-EXO1#2 (sc-44880-SH) was purchased from Santa Cruz Biotechnology.

    Techniques: Western Blot, Flow Cytometry, Expressing

    Decreased levels of serum miR-145 in BCa patients and PLCε was a direct target of miR-145 in BCa cells. A. Comparison of miR-145 levels in three cell lines by qPCR. vs SV-HUC-1. B. Expression levels of miR-145 in T24 and BIU cells transfected with miR-145 mimics and NC. C, D. PLCε mRNA and protein expression levels in the BCa cell lines detected by qRT-PCR and western blotting after transfection with miR-145 mimics. E. Schematic representation of the predicted miR-145 binding sites in 3’UTR of PLCε. F. Wild-type or mutant 3’UTR of PLCε gene reporter plasmid was co-transfected with miR-145mimics or NC into T24, followed by luciferase reporter assays. vs miR-NC. G. Changes of PLCε expression analysised by qPCR in BCa cells after treating with cisplatin or (and) miR-145. H, I. 8 μg/mL Cisplatin was treated in BCa cells for 48 h. H. Viability of BCa cells with cisplatin or (and) miR-145 mimics treatment detected by CCK-8. I. Western blotting analysis showing the expression of PLCε, EXO1, and γH2AX after cisplatin or (and) miR-145 mimics treatment for 48 h. J. The serum miR-145 expression in 40 patients with BCa, 19 patients with urinary benign diseases (BBD) and 21 healthy controls (Normal) were obtained by qPCR. Expression levels of miR-145 were normalized to U6. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Journal: American Journal of Cancer Research

    Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

    doi:

    Figure Lengend Snippet: Decreased levels of serum miR-145 in BCa patients and PLCε was a direct target of miR-145 in BCa cells. A. Comparison of miR-145 levels in three cell lines by qPCR. vs SV-HUC-1. B. Expression levels of miR-145 in T24 and BIU cells transfected with miR-145 mimics and NC. C, D. PLCε mRNA and protein expression levels in the BCa cell lines detected by qRT-PCR and western blotting after transfection with miR-145 mimics. E. Schematic representation of the predicted miR-145 binding sites in 3’UTR of PLCε. F. Wild-type or mutant 3’UTR of PLCε gene reporter plasmid was co-transfected with miR-145mimics or NC into T24, followed by luciferase reporter assays. vs miR-NC. G. Changes of PLCε expression analysised by qPCR in BCa cells after treating with cisplatin or (and) miR-145. H, I. 8 μg/mL Cisplatin was treated in BCa cells for 48 h. H. Viability of BCa cells with cisplatin or (and) miR-145 mimics treatment detected by CCK-8. I. Western blotting analysis showing the expression of PLCε, EXO1, and γH2AX after cisplatin or (and) miR-145 mimics treatment for 48 h. J. The serum miR-145 expression in 40 patients with BCa, 19 patients with urinary benign diseases (BBD) and 21 healthy controls (Normal) were obtained by qPCR. Expression levels of miR-145 were normalized to U6. *P ≤ 0.05, **P ≤ 0.01, and ***P < 0.001.

    Article Snippet: Vector-sh-EXO1#2 (sc-44880-SH) was purchased from Santa Cruz Biotechnology.

    Techniques: Expressing, Transfection, Quantitative RT-PCR, Western Blot, Binding Assay, Mutagenesis, Plasmid Preparation, Luciferase, CCK-8 Assay

    A mechanism for PLCε depletion-mediated cisplatin sensitivity of BCa. Schematic diagram describing the functional significance of PLCε in BCa cells. PLCε regulate EXO1 medicated-cell cycle, proliferation, apoptosis and cisplatin sensitivity through nuclear translocation of p-ATM and can be regulated by miR-145.

    Journal: American Journal of Cancer Research

    Article Title: Phospholipase C-ε regulates bladder cancer cells via ATM/EXO1

    doi:

    Figure Lengend Snippet: A mechanism for PLCε depletion-mediated cisplatin sensitivity of BCa. Schematic diagram describing the functional significance of PLCε in BCa cells. PLCε regulate EXO1 medicated-cell cycle, proliferation, apoptosis and cisplatin sensitivity through nuclear translocation of p-ATM and can be regulated by miR-145.

    Article Snippet: Vector-sh-EXO1#2 (sc-44880-SH) was purchased from Santa Cruz Biotechnology.

    Techniques: Functional Assay, Translocation Assay